Advertisement

NightDragon Acquisition Corp. NDAC

Set alert

Price alert · NDAC

All alert types
10.08 0.00 0.00%

As of Dec 2, 3:13 PM ET

10.01 Day range 10.08
9.56 52-week range 10.08
Open
10.02
Prev close
10.08
Mkt cap
444.93M
Vol
59.13K
Avg vol
203.22K
EPS
0.11
P/E
91.59
Div yield
0.00%
More statistics
Low
10.01
High
10.08
Forward P/E
0.00
Beta
0.00
Short ratio
3.39
Inst. own
87.67%
Dividend
0.00
Ex-div date
50-d avg
10.01
200-d avg
9.84
1y target
0.00

6M chart

Chart tools
Interval

Signals (27)
NameDateAgo
RSI: OverboughtDec 2, 20223 years ago
RSI: OverboughtNov 4, 20223 years ago
MACD: Sell SignalOct 26, 20224 years ago
RSI: OverboughtOct 24, 20224 years ago
RSI: OverboughtOct 3, 20224 years ago
SMA: BullishSep 30, 20224 years ago
MACD: Buy SignalSep 30, 20224 years ago
SMA: BullishSep 29, 20224 years ago
MACD: Sell SignalSep 26, 20224 years ago
MACD: Buy SignalSep 20, 20224 years ago
MACD: Sell SignalAug 11, 20224 years ago
MACD: Buy SignalJul 14, 20224 years ago
SMA: BullishJul 12, 20224 years ago
SMA: BullishJul 12, 20224 years ago
SMA: BearishJul 11, 20224 years ago
SMA: BearishJul 11, 20224 years ago
MACD: Sell SignalJul 11, 20224 years ago
SMA: BullishJul 7, 20224 years ago
SMA: BullishJul 7, 20224 years ago
MACD: Buy SignalJul 7, 20224 years ago
SMA: BearishJul 6, 20224 years ago
SMA: BullishJul 1, 20224 years ago
SMA: BearishJun 30, 20224 years ago
MACD: Sell SignalJun 30, 20224 years ago
SMA: BullishJun 22, 20224 years ago
MACD: Buy SignalJun 22, 20224 years ago
MACD: Sell SignalJun 14, 20224 years ago

Key statistics

Market cap
444.93M
Enterprise value
444.43M
Trailing P/E
91.59
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
0.11
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
0
Total cash
498.83K
Total debt
0
Return on equity
0.00%
Shares outstanding
35.53M
Short % of float
2.56%
50-day average
10.01
200-day average
9.84

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NDAC Revenue — quarterly 0
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022
NDAC Net income — quarterly 1.87M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022
NDAC EPS — quarterly 0.04
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 2022

About NightDragon Acquisition Corp.

NightDragon Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify business opportunities in the field of cybersecurity, safety, security, and privacy sectors. The company was incorporated in 2020 and is based in San Francisco, California.

Sector
Financial Services
Industry
Shell Companies
Country
United States
Website
ndac.com

News

Your note

Sign in to keep a note on NDAC — it syncs with the Stock Master app.

Institution ownership

NDAC institution ownership
Holder% heldSharesValueReported
Millennium Management Llc6.26%2,222,94022.40MSep 29, 2022
Citadel Advisors Llc5.91%2,099,18621.15MSep 29, 2022
Sculptor Capital Lp4.78%1,697,20517.10MSep 29, 2022
Marshall Wace LLP4.41%1,566,52315.78MSep 29, 2022
Ion Asset Management Limited4.33%1,538,76415.50MSep 29, 2022
TD Asset Management, Inc4.19%1,487,90014.99MSep 29, 2022

Fund ownership

NDAC fund ownership
Holder% heldSharesValueReported
Blackstone Alternative Multi-Strategy Fund1.31%465,0004.69MSep 29, 2022
CrossingBridge Pre-Merger SPAC ETF0.16%58,124585.62KSep 29, 2022
Investment Managers Ser Tr II-First Trust Merger Arbitrage Fd0.09%32,925331.73KSep 29, 2022
Franklin K2 Alternative Strategies Fd0.06%21,996221.62KAug 30, 2022
AQR Funds-AQR Diversified Arbitrage Fd0.05%16,410165.34KSep 29, 2022
Fidelity NASDAQ Composite Index Fund0.03%10,595106.75KAug 30, 2022
Advertisement